Agreement between QLE’s South African subsidiary and Necsa related to the siting, design, construction, commission and operation of an enrichment facility on the Necsa site in Pelindaba, with QLE’s objective to achieve market readiness for production of nuclear fuel The collaboration leverages QLE’s in-licensed and proprietary enrichment technology and Necsa’s globally-recognized production facilities DALLAS, Feb. 23, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that on ...

Core Insights - Quantum Leap Energy LLC (QLE), a subsidiary of ASP Isotopes Inc. (ASPI), has established a Strategic Advisory Board (SAB) to enhance its capabilities in the nuclear fuel cycle [1][3] - The SAB includes industry leaders Mary Lou Dunzik-Gougar and Kevin Kramer, who bring extensive expertise in nuclear engineering and advanced materials [1][4][5] - QLE is focused on developing proprietary technologies to address inefficiencies and environmental concerns in the nuclear fuel cycle, emphasizing modular and scalable designs [2][6] Company Overview - QLE is dedicated to advancing technologies across critical segments of the nuclear fuel cycle, including uranium conversion and isotopic separation [7][8] - The company aims to fill gaps in the nuclear fuel supply chain for advanced reactors and fusion systems through exclusive rights to proprietary technologies [8] - ASP Isotopes Inc. focuses on producing isotopes for various industries, with an initial emphasis on healthcare and technology, and plans to enrich isotopes for the nuclear energy sector [9] Strategic Initiatives - The formation of the SAB is seen as a significant step in QLE's commercial evolution, expected to accelerate market entry and deepen strategic partnerships [3] - QLE intends to leverage ASPI's proprietary isotope separation technologies, which offer advantages such as reduced capital expenditure and enhanced flexibility [6] - The company has established partnerships with industry leaders like TerraPower and Fermi America to accelerate the commercialization of critical isotopes [8]

Core Insights - ASP Isotopes Inc. (ASPI) announced plans for its subsidiary Quantum Leap Energy LLC (QLE) to establish a global corporate headquarters in Austin, Texas, enhancing its operational presence and customer service capabilities in the U.S. [1][2] Group 1: Company Developments - QLE aims to build a significant operational presence in Texas, focusing on a joint venture with Fermi America to develop a high-assay-low enriched uranium (HALEU) enrichment facility and a commercial production facility for stable isotopes and advanced nuclear materials [2][3] - The establishment of QLE's headquarters is strategically timed as advanced reactor technologies are rapidly being developed to meet the increasing clean power demands, particularly for AI data centers and industrial electrification [3] Group 2: Industry Context - Texas is positioned as a leader in energy production and has a supportive regulatory environment for the nuclear sector, which is crucial for attracting talent and infrastructure necessary for QLE's growth [3] - The U.S. Department of Energy projects a need for 50 metric tons of HALEU per year by 2035, escalating to 500 metric tons per year by 2050, indicating a significant demand for advanced nuclear fuels [3] Group 3: Company Focus and Technology - Quantum Leap Energy is dedicated to advancing technologies across critical segments of the nuclear fuel cycle, including uranium conversion, enrichment, and isotopic separation, while also focusing on radioactive waste treatment technologies [4] - The company utilizes proprietary technologies such as the Aerodynamic Separation Process (ASP) and laser-based Quantum Enrichment (QE) to address gaps in the nuclear fuel supply chain for advanced reactors and fusion systems [4] Group 4: Strategic Partnerships - QLE has established strategic partnerships with industry leaders like TerraPower and Fermi America to accelerate the commercialization of critical isotopes essential for next-generation nuclear energy systems [4]

Company Overview - ASP Isotopes Inc. is a development stage advanced materials company focused on producing isotopes for various industries using proprietary technology known as the Aerodynamic Separation Process (ASP technology) [3] - The company's initial focus is on highly enriched isotopes for the healthcare and technology sectors, with plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology [3] - ASP Isotopes has isotope enrichment facilities located in Pretoria, South Africa, dedicated to enriching light isotopes [3] Recent Developments - ASP Isotopes Inc. announced that its subsidiary, Quantum Leap Energy LLC, has confidentially submitted a draft registration statement on Form S-1 to the SEC for a proposed initial public offering of QLE's Class A common stock [1] - The number of shares to be offered and the price range for the proposed offering have not yet been determined, and the IPO is subject to SEC review and market conditions [1]

Core Viewpoint - Quantum Leap Energy LLC, a subsidiary of ASP Isotopes Inc., has initiated a private placement offering of convertible notes amounting to US$64.3 million to accredited investors and certain non-U.S. persons [1][6] Group 1: Offering Details - The offering will lead to the automatic conversion of QLE's outstanding convertible promissory notes issued in March and June 2024 [2] - The convertible notes will be unsecured and convertible into common equity securities of QLE, contingent upon specific events such as an IPO or future equity financing, at a price per share equal to the lower of 80% of the transaction price or a set valuation cap [3] - The notes will mature five years after the initial closing unless converted earlier, and QLE cannot repay the notes prior to maturity unless a change of control occurs [4] Group 2: Use of Proceeds - QLE plans to utilize the net proceeds from the offering to construct and develop laser enrichment production facilities and for general corporate purposes [5] Group 3: Investor Participation - The offering is targeted at institutional investors qualifying as accredited investors or non-U.S. persons, and the notes will not be registered under the Securities Act [7] - Additional notes may be issued in future closings to non-U.S. investors outside the United States [8] Group 4: Company Overview - ASP Isotopes Inc. focuses on developing technologies for isotope production, employing proprietary Aerodynamic Separation Process technology, with initial efforts in healthcare and technology sectors [10] - The company is also developing Quantum Enrichment technology for the nuclear energy sector and has facilities in Pretoria, South Africa [10] Group 5: Market Demand - There is increasing demand for isotopes like Silicon-28 for quantum computing and various isotopes for healthcare and green energy applications [11][12]

Core Viewpoint - ASP Isotopes, Inc.'s subsidiary, Quantum Leap Energy LLC, has acquired assets from One 30 Seven Inc. to enhance its capabilities in nuclear waste decontamination, particularly focusing on water-soluble nuclear waste [1][8]. Acquisition Details - Quantum Leap Energy acquired substantially all assets of One 30 Seven, including an international patent application for treating radioactively contaminated water [2][8]. - The acquisition aims to increase vertical integration in the nuclear fuel cycle, allowing QLE to operate in critical segments such as Conversion, Deconversion, Enrichment, and Nuclear Waste processing [6][8]. Technology and Development - The technology acquired will enable the development of Creber Units, which accelerate the beta decay of high-level waste isotopes like Cesium-137 and Strontium-90, converting them into stable isotopes [3][6]. - Creber Units will be available in four sizes (Micro, Mini, Midi, and Maxi), designed for modular deployment and rapid revenue generation [4][8]. Market Context - The Department of Energy's estimated liability for failing to dispose of commercial spent fuel was $44.5 billion in 2024, highlighting the urgent need for effective nuclear waste management solutions [3][6]. - There are approximately 390,000 Metric Tons of radioactive waste globally, with over 90,000 Metric Tons located in the United States [6]. Financial Aspects - The upfront purchase price for the assets was $150,000 and 266,113 shares of ASPI common stock, with potential additional payments based on the successful completion of Creber Units [9][10]. - QLE has entered into a royalty agreement with One 30 Seven, agreeing to pay a 6.0% royalty on net revenues from product sales for 15 years [11].

Core Points - ASP Isotopes Inc. has appointed Robert Ainscow as Interim CEO while Paul Mann takes a temporary leave of absence for health reasons [1][3] - Michael Cunniffe has been appointed as CFO of Quantum Leap Energy LLC, effective October 1, 2025 [6][7] Company Leadership Changes - Paul Mann will transition to the role of Executive Chairman, focusing on overall leadership and strategic direction [2] - Robert Ainscow, co-founder and current COO, will manage CEO responsibilities and maintain key industry relationships during Mann's recovery [5][4] Health Update - Paul Mann underwent successful orthopedic surgery on September 19, 2025, but his recovery may take several months [3] Upcoming Investor Events - ASP Isotopes will host an Institutional Investor Access Event in South Africa on November 12 and 13, 2025 [9] - The company plans to provide quarterly business updates starting in November 2025 [11] Company Overview - ASP Isotopes Inc. focuses on developing technology for isotope production, particularly for healthcare and technology industries [12] - The company employs proprietary Aerodynamic Separation Process technology and has facilities in Pretoria, South Africa [12][13]

Company Overview - ASP Isotopes Inc. is an advanced materials company focused on developing technology and processes for isotope production across multiple industries [13] - The company employs proprietary technology, the Aerodynamic Separation Process, and aims to produce highly enriched isotopes for healthcare and technology, as well as nuclear energy using Quantum Enrichment technology [13][14] Leadership Appointment - Dr. Ryno Pretorius has been appointed as the Chief Executive Officer of Quantum Leap Energy LLC, a subsidiary of ASP Isotopes, which is focused on developing advanced nuclear fuels [1][5] - Paul Mann will continue as the chairman and CEO of ASP Isotopes and chairman of QLE [2] Dr. Ryno Pretorius' Background - Dr. Pretorius has over 15 years of experience as a chemical engineer, including four years at Necsa, where he gained insights into the nuclear fuel supply chain [3] - He has served as technical director and CEO of Free Radical Process Design, a consulting firm that has worked with ASP Isotopes on isotope enrichment challenges [3] Strategic Initiatives - QLE is preparing for a spin-out anticipated in the second half of 2025, which involves building a senior leadership team to establish it as a standalone company [5] - The company has entered into a loan agreement with TerraPower for financing the construction of a uranium enrichment facility in South Africa [7] Technology and Market Potential - ASP Isotopes believes its Quantum Enrichment process can produce High Assay Low-Enriched Uranium (HALEU) at competitive prices, promoting the adoption of new nuclear energy [8] - The Nuclear Energy Institute estimates a potential HALEU supply demand of approximately 3,000 metric tons by 2035, with indications that actual demand may be higher [10] Future Energy Landscape - Global energy consumption is expected to double in the next 30 years, necessitating a zero increase in carbon emissions to meet 2050 climate goals [11] - Advanced nuclear fuels, particularly HALEU, will be essential for the operation of future small modular reactors [10][11]

Core Insights - ASP Isotopes Inc. is undergoing a strategic separation of its Nuclear Fuels Business and Specialist Isotope Products into two independent companies, with plans to complete this by the second half of 2025 [2][5][8] - Mr. Sipho Maseko has joined the board of directors of ASP Isotopes, bringing extensive experience from his previous roles in telecommunications and industrial sectors [1][3][4] - Dr. Hendrik Strydom has transitioned from the board of directors of ASP Isotopes to the board of managers of Quantum Leap Energy LLC, focusing on advanced nuclear fuel production [2][6][7] Company Developments - The separation will involve a spin-out of Quantum Leap Energy LLC, which aims to develop advanced nuclear fuels such as HALEU and Lithium-6, and will become a separate public company [5][8] - The board of directors is evaluating the optimal composition for the board of managers of Quantum Leap Energy LLC, with Dr. Strydom now part of this team [6][7] - The company is committed to maximizing shareholder value during the separation process and will consider various options to achieve this [8] Leadership and Expertise - Mr. Maseko has a strong background in various industries, including telecommunications and energy, and has been instrumental in advancing ASP Isotopes' business in South Africa [3][4] - Dr. Strydom has a 40-year career in isotope enrichment and has previously worked on nuclear fuel programs, enhancing the company's technical capabilities [6][7] Market Focus - ASP Isotopes is dedicated to producing isotopes for multiple industries, including healthcare and technology, and is developing proprietary technologies for isotope enrichment [10][11] - There is a growing demand for isotopes in emerging applications, particularly in quantum computing and green energy, which the company aims to address [11]